Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-HOBA in Systemic Lupus Erythematosus
NCT07225543Phase 2Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- May 2026
- Primary completion
- Jul 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 2-hydroxybenzylamine in systemic lupus erythematosus (SLE), hypertension (HTN), sponsored by Vanderbilt University Medical Center. Started May 2026; status: recruiting.
02
Drugs
2-hydroxybenzylamine
03
Conditions
systemic lupus erythematosus (SLE)hypertension (HTN)
Beyond the preview
Go deeper on NCT07225543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07225543.